Insomnia Treatment and Problems (the iTAP Study)
iTAP
2 other identifiers
interventional
56
1 country
1
Brief Summary
This project aims to evaluate the efficacy of insomnia treatment in improving insomnia symptoms and alcohol-related problems among heavy-drinking young adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2018
CompletedFirst Posted
Study publicly available on registry
August 13, 2018
CompletedStudy Start
First participant enrolled
August 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2019
CompletedResults Posted
Study results publicly available
June 4, 2020
CompletedJune 16, 2020
June 1, 2020
1.1 years
July 23, 2018
April 27, 2020
June 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Insomnia Severity
Assessed using the Insomnia Severity Index. Scores range from 0 to 28, with higher scores indicating higher insomnia severity.
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Sleep Efficiency
Assessed using daily sleep diaries and actigraphy -- sleep efficiency is the proportion of time spent in bed (from lights out until out of bed in the morning) that is actually spent sleeping (subtracting how long it took to fall asleep and how much time was spent awake in the middle of the night).
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Sleep Quality
Assessed using a single question on the daily sleep diary. Sleep quality score ranges from 0-4, where 0=very poor sleep quality and 4=very good sleep quality.
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Drinking Quantity
Assessed using the Daily Drinking Questionnaire. Participants estimate how many alcoholic drinks they typically consume on each day of the week, averaged over the past 3 months.Responses for drinking quantity range from 0 to infinity, where higher numbers indicate more standard drinks consumed per day. Reports from each day are summed to create a "Drinks Per Week" score. Participants also report the amount of time they typically spend drinking during each day of the week. Responses range from 0-24 hours per day, where higher numbers indicate more hours drinking.
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Alcohol-related Consequences
Assessed using the Brief Young Adult Alcohol Consequences Questionnaire. Scores range from 0-24, with higher scores indicating more alcohol-related consequences.
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Secondary Outcomes (4)
Delay Discounting
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Negative Affect
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Emotion Regulation
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Alcohol Craving
Change from baseline to post-treatment (week 8) to 1 month follow-up (week 12)
Study Arms (2)
CBT-I
EXPERIMENTALIndividual Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered once a week for 6 weeks
Sleep Hygiene
ACTIVE COMPARATORSleep hygiene handout delivered once to all participants
Interventions
Participants assigned to the CBT-I condition will attend 1-hour individual sessions of CBT-I once a week for five weeks. Consistent with clinical guidelines (Schutte-Rodin, Broch, Buysse, Dorsey, \& Sateia, 2008), treatment will include stimulus control (e.g., limit use of bed to sleep or sexual activity, get out of bed if lying awake for more than 20 minutes), sleep restriction (limit time in bed to amount of time spent sleeping on a typical night), sleep hygiene (e.g., avoid exercise within 2 hours of bedtime, create cool and dark sleep environment), relaxation training, and cognitive restructuring.
All participants will receive a one-page handout on sleep hygiene. This is the only intervention that participants assigned to the Sleep Hygiene condition will receive and is consistent with what may be expected as standard care in a doctor's visit with a primary care physician.
Eligibility Criteria
You may qualify if:
- Age 18-30 years
- Heavy episodic drinking, defined as 1 heavy drinking episode (4/5+ drinks for women/men) in the past 30 days on the Timeline Followback
- DSM-5 criteria for insomnia, with "daytime impairment" operationalized as ISI scores =\>10
You may not qualify if:
- Unable to provide informed consent
- New sleep medication in the past 6 weeks
- Contraindications for CBT-I (mania or seizure disorder)
- Severe psychiatric disorder that requires clinical attention (PTSD, major depression)
- Current treatment for insomnia or alcohol use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri-Columbia
Columbia, Missouri, 65212, United States
Related Publications (4)
Miller MB, Carpenter RW, Freeman LK, Curtis AF, Yurasek AM, McCrae CS. Cannabis use as a moderator of cognitive behavioral therapy for insomnia. J Clin Sleep Med. 2022 Apr 1;18(4):1047-1054. doi: 10.5664/jcsm.9796.
PMID: 34870584DERIVEDMiller MB, Curtis AF, Hall NA, Freeman LK, Everson AT, Martinez LD, Park CJ, McCrae CS. Daily associations between modifiable sleep behaviors and nighttime sleep among young adult drinkers with insomnia. J Clin Sleep Med. 2022 Mar 1;18(3):703-712. doi: 10.5664/jcsm.9706.
PMID: 34605392DERIVEDMiller MB, Freeman LK, Deroche CB, Park CJ, Hall NA, McCrae CS. Sleep and alcohol use among young adult drinkers with Insomnia: A daily process model. Addict Behav. 2021 Aug;119:106911. doi: 10.1016/j.addbeh.2021.106911. Epub 2021 Mar 15.
PMID: 33773200DERIVEDMiller MB, Deroche CB, Freeman LK, Park CJ, Hall NA, Sahota PK, McCrae CS. Cognitive behavioral therapy for insomnia among young adults who are actively drinking: a randomized pilot trial. Sleep. 2021 Feb 12;44(2):zsaa171. doi: 10.1093/sleep/zsaa171.
PMID: 32886778DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Mary Beth Miller
- Organization
- University of Missouri
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Beth Miller, PhD
University of Missouri-Columbia
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- PI Miller will not be blinded to block size or participant assignment because she will inform study therapists of participant assignment to conditions. However, PI Miller and study therapists will be blinded to assessment outcomes, and the assessment RA will be blinded to participant condition. All participants will be told that they will be assigned to one of two insomnia treatment conditions in order to blind them to condition assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Psychiatry
Study Record Dates
First Submitted
July 23, 2018
First Posted
August 13, 2018
Study Start
August 29, 2018
Primary Completion
September 27, 2019
Study Completion
September 27, 2019
Last Updated
June 16, 2020
Results First Posted
June 4, 2020
Record last verified: 2020-06